课题基金 / 基金详情

Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in the Progression of Diabetic Nephropathy: Friend or foe?

Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in the Progression of Diabetic Nephropathy: Friend or foe?
核因子红细胞 2 相关因子 2 (Nrf2) 在糖尿病肾病进展中：是友还是敌？
批准号：
321283
负责人：
Chan John S
金额：
$47.82万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-03-01 至 2020-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=321283&lang=en
关键词：
Angiotensinogen Diabetes Diabetic Nephropathy Heterogeneous Nuclear Ribonucleoproteins Hypertension Knockout Mice Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Oxidative Stress Renin-Angiotensin System Transgenic Mice

项目摘要

项目成果

Chan John S的其他基金

相似基金

相关文献

中文摘要
翻译
糖尿病和持续性高血压是心血管疾病、中风、心脏病发作和肾衰竭的两大危险因素。强化胰岛素治疗和使用称为肾素-血管紧张素系统(RAS)的激素系统抑制剂进行慢性治疗
英文摘要
Diabetes and persistent hypertension are two major risk factors for cardiovascular disease, stroke, heart attack and kidney failure. Intensive insulin therapy and chronic treatment with inhibitors of a hormonal system called renin-angiotensin system (RAS)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes
Reactive Oxygen Species, Bcl-2-Modifying Factor and Tubular Atrophy in Diabetic Kidneys
海外基金